Advertisement

Topics

Chugai Pharmaceutical Co., Ltd Company Profile

14:57 EDT 20th June 2018 | BioPortfolio

Chugai Pharmaceutical Co., Ltd. places tremendous importance on the safekeeping of personal information obtained from customers using our website (information that is personally identifiable such as your name, address, e-mail address, or phone number, and that is not otherwise publicly available). Based on our Privacy Policy the following regulations have been implemented to insure that this information is strictly safeguarded and that the utmost care is given to the handling of the information.

Contact

Email: pr@chugai-pharm.co.jp


News Articles [322 Associated News Articles listed on BioPortfolio]

Chugai Pharma receives Taiwan FDA approval for Alecensa to treat ALK─positive NSCLC

Chugai Pharmaceutical Co., Ltd. announced that Chugai Pharma Taiwan Ltd., a wholly owned subsidiary of Chugai, obtained approval from the Taiwan Food and Drug Administration (TFDA), for "Alecensa,"

BRIEF—Chugai’s Mircera injection syringe 12.5μg approved in Japan

Japanese drug major Chugai Pharmaceutical says it has obtained approval from the Ministry of Health,…

BRIEF—Chugai files for Japanese approval of additional indication for Hemlibra

Chugai Pharmaceutical, which is majority-owned by Swiss pharma giant Roche, has filed an application…

Chugai Presents Results of Two Pivotal Phase lll Studies for its Bispecific Antibody HEMLIBRA at WFH 2018

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) today announced that full results from HAVEN 3 study (NCT02847637) and HAVEN 4 study (NCT03020160) evaluating Chugai's hemophilia A treatment HEMLIBRA ...

China FDA to review Chugai's regulatory submission for Edirol

Shares in Japanese drugmaker Chugai Pharmaceutical are up almost 5% on news that the China Food and Drug…

Japan gets access to Chugai's unresectable advanced/recurrent NSCLC therapy

Chugai Pharmaceutical's Tecentriq, or atezolizumab, intravenous infusion 1,200 mg was launched in Japan as treatment for pati -More- 

Chugai abandons patent infringement lawsuit

Chugai Pharmaceutical] announced today that it has decided to waive its claim in a patent infringement…

BRIEF—Chugai debuts Tecentriq in Japan for NSCLC

Japan’s Chugai Pharmaceutical has launched Tecentriq (atezolizumab, an intravenous Infusion) recombinant…

PubMed Articles [461 Associated PubMed Articles listed on BioPortfolio]

Pharmaceutical cocrystals as an opportunity to modify drug properties: From the idea to application. A review.

The properties of many drugs which have been available on the pharmaceutical market for a long time still need to be improved. Cocrystals are the solid state drug modification which can improve such p...

Total Health-related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers.

This study aimed to examine a detailed breakdown of costs (absenteeism, presenteeism, and medical/pharmaceutical expenses), of the employees in four pharmaceutical companies in Japan.

Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs.

Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the...

Applications of various analytical techniques in quality control of pharmaceutical excipients.

Although excipients are pharmacologically inert substances, still they are integral and significant ingredients of a pharmaceutical formulation. Their amount and concentration level along with the act...

The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis.

The non-medical use (NMU) of pharmaceutical drugs is an increasing public health concern. This systematic review consolidates current knowledge about how pharmaceutical drugs are obtained for NMU and ...

Clinical Trials [302 Associated Clinical Trials listed on BioPortfolio]

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Individualized Pharmaceutical-care in Outpatients With Cancer Pain

The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients

Companies [1040 Associated Companies listed on BioPortfolio]

Chugai Pharma Europe Ltd

Chugai Pharmaceutical Co., Ltd is headquartered in Tokyo, Japan. In its home market, Chugai is a household name, with a broad-ranging product portfolio encompassing highly specialised therapeutic anti...

Chugai Pharma Europe Limited

European headquarters of Chugai Pharmaceutical Co. Ltd. and Chugai Pharma UK Ltd.

Chugai Pharmaceutical Co., Ltd

Chugai Pharmaceutical Co., Ltd. places tremendous importance on the safekeeping of personal information obtained from customers using our website (information that is personally identifiable such as y...

Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Company Limited

BioHealthcare Oncology

More Information about "Chugai Pharmaceutical Co., Ltd" on BioPortfolio

We have published hundreds of Chugai Pharmaceutical Co., Ltd news stories on BioPortfolio along with dozens of Chugai Pharmaceutical Co., Ltd Clinical Trials and PubMed Articles about Chugai Pharmaceutical Co., Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chugai Pharmaceutical Co., Ltd Companies in our database. You can also find out about relevant Chugai Pharmaceutical Co., Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record